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ABSTRACT
Objective: This prospective study was designed to 1) determine the prevalence of group B strepto-
coccus (GBS) in our obstetric population and 2) evaluate the predictive value of lower vaginal/
perianal GBS cultures obtained in each trimester of pregnancy relative to GBS culture status at
delivery.
Methods: Lower vaginal/perianal GBS cultures were obtained in the first trimester, at 26-28
weeks, at 37 weeks, and on admission for delivery. The investigators were blinded to the results of
all cultures except those obtained at 37 weeks. The sensitivity, specificity, and positive (PPV) and
negative predictive values (NPV) ofeach group of cultures with respect to culture status at delivery
were determined, and the pattern of GBS carriage in our patients was delineated.
Results: Nine hundred seventy-three patients participated in this longitudinal study. The preva-
lence ofGBS carriage was 14.0% in the first trimester, 13.9% at 26-28 weeks, 12.4% at 37 weeks,
and 12.1% at delivery. GBS carriage was continuous (all 4 cultures positive) in 3.8% and identified
on a single culture only in 7.8%. Sensitivity (S1), specificity ($2), PPV, and NPV for each set of
antepartum cultures with respect to culture status at delivery were as tabled:
Delivery GBS status (%)
S $2 PPV NPV
First trimester 49.5 91.8 45.5 92.9
26-28 weeks 68.4 93.9 60.4 95.6
37 weeks 63.3 94.5 61.3 95.0
Conclusions: The pattern of GBS carriage in pregnancy is highly variable. Regardless of when
antenatal GBS cultures are done, they serve as poor predictors of maternal GBS carriage at
delivery. Infect. Dis. Obstet. Gynecol. 5:237-243, 1997. (C) 1997 Wiley-Liss, Inc.
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he group B beta-hemolytic streptococcus (GBS)
is recognized as a significant perinatal patho-
gen, being responsible for 1.8 cases of neonatal sep-
sis per 1,000 live births each year in the United
States. 1,e The vast majority of these neonatal in-
fections are the result of peripartum vertical trans-
mission from a GBS colonized mother.3 Gastroin-
testinal GBS colonization has been recognized as
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the major source of genital tract seeding in preg-
nancy, and lower vaginal colonization with GBS at
the time of delivery represents the major determin-
ing factor of mother-to-infant transmission.4
The reported incidence of lower vaginal/peri-
anal GBS colonization in pregnancy varies from 15
to 40%.s-7 When maternal vaginal GBS coloniza-
tion is present at delivery, approximately 70-75%
of delivered infants will be colonized.8 Of term
infants colonized with GBS, 1-2% will develop a
GBS-related infection, whereas preterm infants are
at a significantly higher risk of infection with an 8%
attack rate. 7,s Reported neonatal mortality rates
range from 5 to 20%, with the potential for lethal
infection highest in preterm infants. 1,e GBS is also
a major cause of puerperal sepsis, being the most
common isolate in chorioamnionitis and accounting
for 20% of cases of endometritis.9
The prevention of GBS-related disease in preg-
nancy is dependent on the interruption of peripar-
tal vertical transmission. Intrapartum therapy of
GBS carriers with systemic antibiotics has been
shown to markedly diminish both neonatal and ma-
ternal puerperal infection rates.1, However, for a
selective intrapartum approach to be effective, a
good predictor of colonization at the time of deliv-
ery is needed. A number of rapid assays for the
detection ofGBS in labor have been developed but
all lack sufficient sensitivity (70-80%) and require
heavy GBS colonization to achieve even that sen-
sitivity level.-1" Longitudinal studies on the pre-
dictive value of prenatal GBS cultures have shown
varied results and differ in the site cultured.3,s,6,8,14,s
Whether antenatal cultures would be useful to re-
liably determine who should receive intrapartum
therapy has thus represented a controversy in the
literature to date. In addition, if screening GBS
cultures were to be routinely obtained, at what ges-
tational age they would best be obtained is unclear.
The primary objective of this study was to
evaluate the predictive value of vaginal/perianal
GBS cultures obtained in each trimester relative to
culture status at delivery. A second objective was to
define the prevalence of GBS carriage in our popu-
lation.
SUBJECTS AND METHODS
Beginning June 15, 1993, all women seen for their
first prenatal visit in the first trimester of pregnancy
at the Marshfield Clinic, a tertiary care center lo-
cated in central Wisconsin, were considered eli-
gible for participation in this study. Recruitment
occurred during the initial visit, and patients who
agreed to participate had vaginal/perianal cultures
done at their first visit, at 26-28 weeks, at 37
weeks, and on admission in labor. The investiga-
tors were blinded to the culture results, except for
the result of the 37 week culture.
Culture specimens were obtained from the
lower vaginal and perianal areas with a single Da-
cron swab, then placed in Amies transport medium
and immediately transferred to the laboratory. The
specimens were then plated directly on colistin na-
lidixic acid (CNA) agar with blood within h of
receipt in the laboratory. Because plating was done
directly to this selective solid media, no subcul-
tures were required. All isolates of streptococci
were serotyped with antisera from Becton Dickin-
son (Cockeysville, MD). Bacterial growth on the
agar plate was quantified based on the quadrant of
the plate involved. Growth in the initial half of the
plate was semiquantitated as light, into the third
quadrant as moderate, and into the fourth quadrant
as heavy.
Without prior knowledge of the prevalence of
GBS carriage in our obstetric population, an esti-
mate on required sample size to fulfill the study
objectives was based on a presumed prevalence of
15%. A comparison of the sensitivity of two culture
times with respect to culture status at delivery was
estimated to require 946 patients to achieve a sta-
tistical power of 0.90 (assuming true sensitivities of
0.8 and 0.9, in a two-sided test with a significance
level of 0.05). Since more than 1,100 new obstetric
patients are seen each year at Marshfield Clinic, it
was anticipated that enrollment would be com-
pleted in year. The study proposal was approved
by the Marshfield Clinic Institutional Review
Board in May 1993.
After delivery of all patients, the culture data
were analyzed to determine the prevalence of GBS
carriage in each trimester and at delivery. The sen-
sitivity, specificity, and positive (PPV) and nega-
tive predictive values (NPV) of cultures in each
trimester with respect to culture status at delivery
were determined. The prevalence of GBS carriage
and the predictive values of cultures were summa-
rized as percents, with 95% confidence limits. The
primary statistical analyses comparing culture re-
suits at different time points were based upon ex-
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TABLE I. GBS study culture times and prevalence
N Time of culture Prevalence
First trimester 973 9.9 + 2.6 14.0 (I 1.8, 16.3)
26-28 weeks 876 27.6 + I. 13.9 (I 1.7, 16.4)
37 weeks 792 37.3 + 0.5 12.4 (10.2, 14.9)
Delivery 832 39.3 + 1.9 12. (10.0, 14.6)
aBased on all available cultures.
bMean + SD (weeks gestation).
CPercent (95% confidence limits).
act results for McNemar’s test of correlated propor-
tions. Chi-square procedures were used to test for
homogeneity of prevalence over age groups and
other demographic characteristics. Multiple logistic
regression analysis was used to jointly evaluate the
association of GBS prevalence with the set of pa-
tient characteristics and to evaluate the use of or-
dinal grading for positive cultures. Results in this
report are deemed statistically significant at the 5%
level of significance (P < 0.05). Analyses were con-
ducted using StatXact and SAS statistical software.
RESULTS
Between June 15, 1993, and December 31, 1994,
1,302 patients presented for prenatal care during
the first trimester at our center. Of these, 1,285
were offered the opportunity to participate in the
study and 973 (76%) enrolled. The 27 additional
patients were recruited in an attempt to compen-
sate for 89 patients lost prior to the second culture.
Continued recruitment to compensate for all 89
was not possible due to financial constraints. En-
rollment ended December 31, 1994, and all en-
rolled patients were delivered by August 15, 1995.
As mentioned, 89 patients were lost from the
study before the second (26-28 week) culture was
obtained due to miscarriage (43), pregnancy termi-
nation (11), move/change of care (30), delivery (3),
or patient decision to withdraw from the study (2).
At the time of the 26-28 week culture, 884 patients
remained, and of these 876 had their cultures done.
Seven hundred ninety-seven patients remained
undelivered by the 37 week appointment with 792
cultures obtained. Delivery cultures were obtained
for 832 patients who delivered after 20 weeks.
Overall, 735 subjects had a complete set of all 4
cultures to evaluate.
The mean gestational age of subject enrollment
was 9.9 _+ 2.6 weeks. The mean times at which
study cultures were obtained and the correspond-
TABLE 2. GBS study culture prevalence in patients
with all 4 cultures
N Prevalence
First trimester 735 13.2 (10.8, 15.9)
26-28 weeks 735 14.0 (I 1.6, 16.7)
37 weeks 735 12.5 (10.2, 15.1)
Delivery 735 12. (9.8, 14.7)
aPercent (95% confidence limits).
ing GBS prevalence at these times based upon
available cultures are summarized in Table 1. In
Table 2, results are presented for those patients in
whom all 4 study cultures were done. Although the
observed GBS prevalence was slightly higher at the
early culture times in comparison to the delivery
culture, this difference was not statistically signifi-
cant.
Table 3 presents the sensitivity, specificity, and
predictive values for each culture time with respect
to culture status at delivery. The observed sensi-
tivities and PPVs were below 50% for the first tri-
mester culture, and were only 60-70% at 26-28 and
37 weeks. For those patients found positive at de-
livery, comparisons of early culture results show a
significant improvement in sensitivity from the
first trimester to 26-28 and 37 weeks (P 0.004 and
P 0.017, respectively), but no difference between
the 26-28 and 37 week cultures (P 0.47). Regard-
less of whether the antenatal culture was done at
26-28 or 37 weeks, PPV and sensitivity with re-
spect to culture status at delivery did not signifi-
cantly improve.
Prevalence data for GBS at the first trimester
visit are presented in Table 4 stratified by various
demographic characteristics. Almost all patients
were white, 86% were currently married, and the
mean age was 27.7 _+ 5.3 years. A significant non-
linear association between prevalence and age was
observed (P 0.008), with the highest prevalence
observed among women in their late 20s. Signifi-
cantly lower prevalence was observed in women
who had experienced a prior miscarriage (9.8% vs.
15.8%, P 0.012) and among those women report-
ing tobacco use (8.49% vs. 15.3%, P 0.013). Mul-
tiple logistic regression served to verify that age,
prior miscarriage, and tobacco use were jointly as-
sociated with GBS prevalence.
Of the 735 patients with complete (all 4) culture
data, cultures were consistently negative in 564 pa-
tients (76.7%). Of 171 patients (23.3%) who were
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TABLE 3. GBS carriage rates with respect to culture status at delivery
Sensitivity Specificity PPV NPV
First trimester 49.5 (39.4, 59.6) 91.8 (89.6, 93.7) 45.5 (35.9, 55.2) 92.9 (90.8, 94.7)
26-28 weeks 68.4 (58.2, 77.4) 93.9 (91.9, 95.5) 60.4 (50.6, 69.5) 95.6 (93.8, 97.0)
37 weeks 63.3 (52.5, 73.2) 94.5 (92.5, 96. I) 61.3 (50.6, 71.2) 95.0 (93.0, 96.5)
aPercent (95% confidence limits).
TABLE 4. Demographics of study population based
on initial culture result
GBS+ GBS P*
0.008 Age (years)
<21
22-25
26-29
30-33
>34
Married
Currently
Other
Race
White
Black
Other
Parity
0
I-2
3-4
>5
Prior miscarriage
Yes
No
Prior PTL
Yes
No
Prior PTD
Yes
No
Prior PPROM
Yes
No
Tobacco use
Yes
No
ETOH use
Yes
No
19(13.1%) 126
8(8.) 20
52 (I 9. I%) 220
35 (I 5.6%) 190
12 (I 0.7%) I00
117 (14.0%) 716
19(13.6%) 121
133 (I 3.9%) 826
2
2
55 (I 5.3%) 305
69 (I 2.9%) 467
12 (I 6.9%) 59
0 6
29 (9.8%) 266
07 (I 5.8%) 571
9 (I 5.0%) S
27 (I 3.9%) 786
0.897
b
0.375
0.012
0.847
9 (I 4.3%) 54 0.999
27 (I 4.0%) 783
6 (11.5%) 46
30(14.1%) 791
15 (8.4%) 164
21 (I 5.3%) 669
7(10.3%) 61
28 (I 4.2%) 771
0.687
0.013
0.379
aPTL, preterm labor; PTD, preterm delivery; PRROM, preterm prema-
ture rupture of the membranes.
bNot tested due to small numbers.
*Probability from chi-square test of equal proportions.
found to be positive for GBS on at least culture,
only 28 (3.8%) were positive on all 4 cultures. In
143 patients (19.5%) GBS carriage was transient or
intermittent. Transient carriers were defined as
having only of 4 cultures positive. Fifty-seven
subjects (7.8%) were positive in culture only,
with 11 (1.5%) of these being positive only on the
delivery culture. Intermittent carriers were defined
as those with 1-3 of the 4 cultures positive. Of the
intermittent carriers, 46 (6.2%) had 2 of 4 cultures
positive for GBS, and 40 (5.5%) were positive for
GBS in 3 of 4 cultures. Table 5 illustrates the var-
ied patterns of GBS carriage which occurred.
Positive GBS culture results were separated by
grade (light, moderate, and heavy carriage), as il-
lustrated in Table 6 for the 26-28 week and labor
cultures. Logistic regression analysis revealed that
the prediction of positive delivery cultures was im-
proved little, if at all, by using the full graded scale.
This result follows from the fact that all positive
grades showed similar colonization rates at delivery
(Table 7).
DISCUSSION
Great efforts have been expended by the obstetric
and pediatric communities as well as the Centers
for Disease Control (CDC) to develop strategies for
the prevention of perinatal GBS morbidity and
mortality. 11,16-18 What role, if any, antenatal GBS
cultures should play in such strategies has been
controversial due to the lack of clinical trials justi-
fying their benefit. The Marshfield Clinic provides
obstetric services for a rural population of central
and northern Wisconsin. Our study was designed to
provide data on the utility of antenatal GBS cul-
tures in a population such as ours by determining
the GBS prevalence, carriage patterns, and predict-
ability of culture status at delivery.
Sample size calculations for planning this study
assumed a prevalence of 15%, and would provide
adequate statistical power to distinguish culture
sensitivities of 80% and 90% (a 10% difference).
The observed prevalence was somewhat lower
than that used for planning, and the observed sen-
sitivities were much lower, reducing the power ac-
tually achieved. However, the actual sample size
provided good estimates of prevalence (Table 1)
and wc were able to demonstrate a significant dif-
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TABLE 5. GBS carriage patterns in patients with all
4 study cultures (N 735)
Code Frequency %
++++ 28 3.8
+++- 13 1.8
++-+ 7 1.0
++-- 9 1.2
+-++ 4 0.5
+-+- 6 0.8
+--+ 3 0.4
/ 27 3.7
-+++ 16 2.2
8 I.I
-+-+ II 1.5
II 1.5
--++ 9 1.2
8 I.I
1.5
564 76.7
aCode: first trimester/26-28 weeks/37 weeks/delivery.
TABLE 6. Graded culture results at 26-28 weeks
vs. labor
Labor culture result
Negative Light Moderate Heavy Total
Graded 26-28 week result
Negative 675 20 7 4 706
Light 21 15 12 4 52
Moderate 14 9 10 4 37
Heavy 9 6 5 2 22
Total 719 50 34 14 817
TABLE 7. Graded results at 26-28 weeks vs.
percent positive at labor
Labor culture result
N % Positive
Graded 26-28 week result
Negative 706 4.4
Light 52 59.6
Moderate 37 62.2
Heavy 22 59.
Overall 817 12.0
ference in the sensitivity of cultures in the first
trimester compared with cultures obtained later.
The observed sensitivities at all culture times
were, however, so low (<70%, Table 3) as to limit
their usefulness as screening tools. Despite the low
observed sensitivities, our study did, however, con-
firm the value of a negative culture at 37 weeks
(NPV of 95%), with approximately 5% of women
missing treatment in labor. This NPV is similar to
those described by Boyer et al.3,19 and Yancey et
al.6 when the 95% confidence limits are consid-
ered.
Not surprisingly, first trimester cultures in our
patients were not useful predictors of culture status
at delivery. However, based on other published
data, we anticipated that the closer to term cultures
were obtained the better predictors they would
serve with respect to culture status at delivery.",6’19
Boyer et al. found a GBS culture utilizing broth
enrichment at 28 weeks to have a sensitivity of 70%
with respect to culture status at delivery and almost
100% positive predictability if done within 5 weeks
of delivery in an inner-city population where the
GBS prevalence was 23%. In a large multicenter
study, however, utilizing a similar culture tech-
nique, it was found that cultures obtained at 23-26
weeks were not reliable predictors of GBS carriage
at delivery,e Our data revealed comparable num-
bers with respect to the 26-28 week culture, but
obtaining the culture at 37 weeks did not improve
predictive values. The PPV of cultures at both 26-
28 and 37 weeks was, however, poor. Nearly 40% of
women culture positive at delivery and thus candi-
dates for chemoprophylaxis would be missed if
only those positive at 26-28 weeks or at 37 weeks
were treated during labor. Uniformity in the
method of obtaining cultures from our patients was
closely monitored during the course of the study
and therefore we do not believe a breech in tech-
nique accounts for this. Rather, we suspect the
relatively low GBS prevalence in our population to
at least in part be the explanation. The lack of
diversity in our population may affect the preva-
lence, but it should not affect the properties (sen-
sitivity and specificity) of the tests. No relatively
common patient characteristics are apparent in our
population base which could make the test less
sensitive, or cultures more difficult to collect. In
fact, wc speculate that the lack of diversity may
actually allow for a more accurate appraisal of the
results due to the lack of other unsuspected or un-
recognized confounding variables in a more hetero-
geneous population. Studies have shown enhanced
detection of GBS with the use of selective broth
media, therefore our laboratories’ use of selective
solid media for culturing could have impacted on
our ability to isolate GBS and thus result in a falsely
low prevalence in our population, el Recently,
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Yancey et al.6 examined the PPV of late anogenital
GBS cultures utilizing broth enrichment and found
a PPV of 87% within 5 weeks of delivery.
The natural history of GBS carriage in a rural
obstetric population has been ascertained from this
study. Although GBS carriage in pregnancy did not
vary significantly by trimester, how individual pa-
tients carried GBS was a highly variable event. The
identification that GBS carriage may be transient,
intermittent, or consistent supports other pub-
lished reports,s
Maternal-infant GBS transmission can occur
even with light vaginal GBS colonization. How-
ever, the density of maternal GBS colonization has
been shown to be an important predictor of trans-
mission to the infant, with the highest rates of
transmission in those who are heavily colonized.1
We attempted to determine if grading of,GBS cul-
tures would be helpful in predicting culture status
at delivery and consistent carriage in pregnancy. In
our population, grading culture results (i.e., light,
moderate, heavy) did not improve the prediction of
culture status at delivery. However, over half of
positive cultures showed light colonization and
with roughly 100 GBS positive women to evaluate
our ability to investigate the value of grading was
limited. Thus, grading GBS cultures was not help-
ful in our data set, but we cannot conclude that
grading has no value.
The cost effectiveness of universal screening re-
mains a major concern particularly in light of the
varied GBS prevalence in different patient popu-
lations. An effective rapid screen for GBS would
obviate these problems but no such test is pres-
ently available. The recent CDC guidelines have
recommended that a strategy for GBS disease pre-
vention be employed whereby intrapartum antibi-
otic therapy is based on risk factors for disease or
based on a positive GBS culture obtained at 35-37
weeks. 17 The American College of Obstetrics and
Gynecology (ACOG) supported the recent CDC
publication but cautioned that limited data on the
utility of GBS antenatal cultures have been pub-
lished. 18 We believe that we have shown that in a
population with a relatively low GBS carriage rate,
antenatal cultures utilizing selective solid media
are poor predictors of GBS carriage at delivery re-
gardless ofwhen they are done. As part of our study
an intrapartum treatment protocol based on ante-
natal cultures obtained at 37 weeks was also con-
ducted. Results of that treatment study and cost
analysis will be the subject of a separate paper. At
present, however, because of our study findings,
our current approach is to base intrapartum chemo-
prophylaxis on clinical risk factors rather than an-
tepartum cultures.
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